Position in XGN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$100,182
-$237,920 QoQ
Shares Held
33,394
-39.9% QoQ
Ownership
0.138%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 91%
Shared 0%
None 9%
Common Shares in XGN Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026Trexquant Investment LP holds $87,777,569 across 14 Diagnostics & Research names. XGN ranks #14 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NTRA |
Natera, Inc.
|
130,479 | $26,094,495 | |
| 2 | MEDP |
Medpace Holdings, Inc.
|
28,516 | $13,693,098 | |
| 3 | TWST |
Twist Bioscience Corp
|
170,107 | $8,083,484 | |
| 4 | GH |
Guardant Health, Inc.
|
85,901 | $7,934,675 | |
| 5 | DHR |
Danaher Corp /De/
|
39,489 | $7,487,114 | |
| 6 | ICLR |
Icon PLC
|
62,628 | $6,930,414 | |
| 7 | WGS |
GeneDx Holdings Corp.
|
77,350 | $4,967,417 | |
| 8 | VCYT |
Veracyte, Inc.
|
130,159 | $4,192,421 |
All Filings in XGN
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $100,182 | 33,394 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $338,102 | 55,609 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $122,043 | 11,105 | Shares | Sole | 2025-11-14 | |
| No filing history on record for this holder in this stock. | ||||||